Relapsing Vulvovaginal Candidiasis: Treatment with Oxygen Therapy and Hyaluronic Acid
DOI:
https://doi.org/10.3889/oamjms.2022.10129Keywords:
Vulvovaginal, Relapse, Candidiasis, Treatment, Oxygen therapy, Hyaluronic acidAbstract
OBJECTIVE. The aim of our open, anecdotical, retrospective, spontaneous trial has been to evaluate the efficacy of the association between high concentration oxygen and hyaluronic acid for treatment of relapsing candidiasis.
METHODS. 45 women (30.9 ±4.4 years) with relapsing candidiasis, and complaining of dryness, dyspareunia, pain, appealing to our Second Opinion Medical Consultation Network, signed an informed consent form and were treated with oxygen/hyaluronic acid therapy treatment, once a week, for a total of five weeks at the outpatient clinic (Healthy Center, Sirio, Fidenza, Italy). The physicians of the Second Opinion Network followed up weekly from remote (WhatsApp, Skype) each treated patient as to state the effectiveness, tolerability, and side effects of the treatment.
RESULTS. The mean VAS and VuAS scores measured at first visit were 2,660 and 2,622 and significantly (p<0,0001) reduced to 1,311 and 0,77 at last visit. The measurements of the vaginal pH and of the vaginal swab after the last treatment session confirmed significantly (p<0.0001) the absence of candidiasis. Three months later in the follow-up, the percentage of patients who had had only one VVC relapse was 4,44% (2/45), a percentage that increased just to 8,8% at six months (4/45). The elastography index was significantly (p<0.0001) increased after the last treatment session (2,55 ± 0,545 vs 4,48 ± 0,505).
CONCLUSIONS. The combined oxygen therapy with hyaluronic acid gave definite therapeutic benefits in this cohort of relapsing candidiasis in the acute phase of the infection. The 6-month follow up, also detected a lower reinfection rate compared with the historical available data. The procedure is totally painless with excellent compliance by patients and no untoward effects.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Willems HM, Ahmed SS, Liu J, Xu Z, Peters BM. Vulvovaginal candidiasis: A current understanding and burning questions. J Fungi (Basel). 2020;6(1):27. https://doi.org/10.3390/jof6010027 PMid:32106438 DOI: https://doi.org/10.3390/jof6010027
Chen Z, Luo T, Huang F, Yang F, Luo W, Chen G, et al. Kangbainian lotion ameliorates vulvovaginal candidiasis in mice by inhibiting the growth of fluconazole-resistant Candida albicans and the dectin-1 signaling pathway activation. Front Pharmacol. 2022;12:816290. https://doi.org/10.3389/fphar.2021.816290 PMid:35140608 DOI: https://doi.org/10.3389/fphar.2021.816290
Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R. Global burden of recurrent vulvovaginal candidiasis: A systematic review. Lancet Infect Dis. 2018;18(11):e339-47. https://doi.org/10.1016/S1473-3099(18)30103-8 PMid:30078662 DOI: https://doi.org/10.1016/S1473-3099(18)30103-8
Van Riel SJ, Lardenoije CM, Oudhuis GJ, Cremers NA. Treating (recurrent) vulvovaginal candidiasis with medical-grade honey-concepts and practical considerations. J Fungi (Basel). 2021;7(8):664. https://doi.org/10.3390/jof7080664 PMid:34436203 DOI: https://doi.org/10.3390/jof7080664
Gonçalves B, Ferreira C, Alves CT, Henriques M, Azeredo J, Silva S. Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors. Crit Rev Microbiol. 2016;42(6):905-27. https://doi.org/10.3109/1040841X.2015.1091805 PMid:26690853 DOI: https://doi.org/10.3109/1040841X.2015.1091805
Murina F, Graziottin A, Felice R, Radici GL, Di Francesco S. The recurrent vulvovaginal candidiasis: Proposal of a personalized therapeutic protocol. ISRN Obstet Gynecol. 2011;2011:806065. https://doi.org/10.5402/2011/806065 PMid:21845227 DOI: https://doi.org/10.5402/2011/806065
Papon N, Courdavault V, Clastre M, Bennett RJ. Emerging and emerged pathogenic Candida species: Beyond the Candida albicans paradigm. PLoS Pathog. 2013;9(9):e1003550. https://doi.org/10.1371/journal.ppat.1003550 PMid:24086128 DOI: https://doi.org/10.1371/journal.ppat.1003550
Nicholls S, MacCallum DM, Kaffarnik FA, Selway L, Peck SC, Brown AJ. Activation of the heat shock transcription factor Hsf1 is essential for the full virulence of the fungal pathogen Candida albicans. Fungal Genet Biol. 2011;48(3):297-305. https://doi.org/10.1016/j.fgb.2010.08.010 PMid:20817114 DOI: https://doi.org/10.1016/j.fgb.2010.08.010
Ciurea CN, Kosovski IB, Mare AD, Toma F, Pintea-Simon IA, Man A. Candida and candidiasis-opportunism versus pathogenicity: A review of the virulence traits. Microorganisms. 2020;8(6):857. https://doi.org/10.3390/microorganisms8060857 PMid:32517179 DOI: https://doi.org/10.3390/microorganisms8060857
Berman J, Sudbery PE. Candida albicans: A molecular revolution built on lessons from budding yeast. Nat Rev Genet. 2002;3(12):918-30. https://doi.org/10.1038/nrg948 PMid:12459722 DOI: https://doi.org/10.1038/nrg948
Garcia MC, Lee JT, Ramsook CB, Alsteens D, Dufrêne YF, Lipke PN. A role for amyloid in cell aggregation and biofilm formation. PLoS One. 2011;6(3):e17632. https://doi.org/10.1371/journal.pone.0017632 PMid:21408122 DOI: https://doi.org/10.1371/journal.pone.0017632
Brand A, Shanks S, Duncan VM, Yang M, Mackenzie K, Gow NA. Hyphal orientation of Candida albicans is regulated by a calcium-dependent mechanism. Curr Biol. 2007;17(4):347-52. https://doi.org/10.1016/j.cub.2006.12.043 PMid:17275302 DOI: https://doi.org/10.1016/j.cub.2006.12.043
Fanning S, Mitchell AP. Fungal biofilms. PLoS Pathog. 2012;8(4):e1002585. https://doi.org/10.1371/journal.ppat.1002585 PMid:22496639 DOI: https://doi.org/10.1371/journal.ppat.1002585
Naglik JR, Challacombe SJ, Hube B. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev. 2003;67(3):400-28. https://doi.org/10.1128/MMBR.67.3.400-428.2003 PMid:12966142 DOI: https://doi.org/10.1128/MMBR.67.3.400-428.2003
Davis DA. How human pathogenic fungi sense and adapt to pH: The link to virulence. Curr Opin Microbiol. 2009;12(4):365-70. https://doi.org/10.1016/j.mib.2009.05.006 PMid:19632143 DOI: https://doi.org/10.1016/j.mib.2009.05.006
Brock M. Fungal metabolism in host niches. Curr Opin Microbiol. 2009;12(4):371-6. https://doi.org/10.1016/j.mib.2009.05.004 PMid:19535285 DOI: https://doi.org/10.1016/j.mib.2009.05.004
Lindquist S. Heat-shock proteins and stress tolerance in microorganisms. Curr Opin Genet Dev. 1992;2(5):748-55. https://doi.org/10.1016/s0959-437x(05)80135-2 PMid:1458023 DOI: https://doi.org/10.1016/S0959-437X(05)80135-2
Hood MI, Skaar EP. Nutritional immunity: Transition metals at the pathogen-host interface. Nat Rev Microbiol. 2012;10(8):525-37. https://doi.org/10.1038/nrmicro2836 PMid:22796883 DOI: https://doi.org/10.1038/nrmicro2836
Bongomin F, Gago S, Oladele RO, Denning DW. Global and multi-national prevalence of fungal diseases-estimate precision. J Fungi (Basel). 2017;3(4):57. https://doi.org/10.3390/jof3040057 PMid:29371573 DOI: https://doi.org/10.3390/jof3040057
Sobel JD. Recurrent vulvovaginal candidiasis. Am J Obstet Gynecol. 2016;214(1):15-21. https://doi.org/10.1016/j.ajog.2015.06.067 PMid:26164695 DOI: https://doi.org/10.1016/j.ajog.2015.06.067
Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. N Engl J Med. 2004;351(9):876-83. https://doi.org/10.1056/NEJMoa033114 PMid:15329425 DOI: https://doi.org/10.1056/NEJMoa033114
Ilkit M, Guzel AB. The epidemiology, pathogenesis, and diagnosis of vulvovaginal candidosis: A mycological perspective. Crit Rev Microbiol. 2011;37(3):250-61. https://doi.org/10.3109/1040841X.2011.576332 PMid:21599498 DOI: https://doi.org/10.3109/1040841X.2011.576332
Carr PL, Felsenstein D, Friedman RH. Evaluation and management of vaginitis. J Gen Intern Med. 1998;13(5):335-46. https://doi.org/10.1046/j.1525-1497.1998.00101.x PMid:9613891 DOI: https://doi.org/10.1046/j.1525-1497.1998.00101.x
García-Closas M, Herrero R, Bratti C, Hildesheim A, Sherman ME, Morera LA, et al. Epidemiologic determinants of vaginal pH. Am J Obstet Gynecol. 1999;180(5):1060-6. https://doi.org/10.1016/S0002-9378(99)70595-8 PMid:10329856 DOI: https://doi.org/10.1016/S0002-9378(99)70595-8
Shivadas A. Vaginitis. In: Cleveland C, editor. Current Clinical Medicine. 2nd ed. Philadelphia, PA: W.B. Saunders; 2010. p. 1259-64.e1. DOI: https://doi.org/10.1016/B978-1-4160-6643-9.00200-9
Paladine HL, Desai UA. Vaginitis: Diagnosis and treatment. Am Fam Physician. 2018;97(5):321-9. PMid:29671516
Naud P, Matos, JC, Magno V. Secreção vaginal e prurido vulvar. In: Duncan BB, Schmidt MI, Giugliani ER, Duncan MS, Giugliani C, editors. Medicina Ambulatorial: Condutas de Atenção Primária Baseadas em Evidências. 4th ed. Porto Alegre: Artmed; 2013.
Rosentul DC, Delsing CE, Jaeger M, Plantinga TS, Oosting M, Costantini I, et al. Gene polymorphisms in pattern recognition receptors and susceptibility to idiopathic recurrent vulvovaginal candidiasis. Front Microbiol. 2014;5:483. https://doi.org/10.3389/fmicb.2014.00483 PMid:25295030 DOI: https://doi.org/10.3389/fmicb.2014.00483
Ben-Ali M, Corre B, Manry J, Barreiro LB, Quach H, Boniotto M, et al. Functional characterization of naturally occurring genetic variants in the human TLR1-2-6 gene family. Hum Mutat. 2011;32(6):643-52. https://doi.org/10.1002/humu.21486 PMid:21618349 DOI: https://doi.org/10.1002/humu.21486
Romani L. Immunity to fungal infections. Nat Rev Immunol. 2011;11(4):275-88. https://doi.org/10.1038/nri2939 PMid:21394104 DOI: https://doi.org/10.1038/nri2939
Wojitani MD, De Aguiar LM, Baracat EC, Linhares IM. Association between mannose-binding lectin and interleukin-1 receptor antagonist gene polymorphisms and recurrent vulvovaginal candidiasis. Arch Gynecol Obstet. 2012;285(1):149-53. https://doi.org/10.1007/s00404-011-1920-z PMid:21655939 DOI: https://doi.org/10.1007/s00404-011-1920-z
Nedovic B, Posteraro B, Leoncini E, Ruggeri A, Amore R, Sanguinetti M, et al. Mannose-binding lectin codon 54 gene polymorphism and vulvovaginal candidiasis: A systematic review and meta-analysis. Biomed Res Int. 2014;2014:738298. https://doi.org/10.1155/2014/738298 PMid:25143944 DOI: https://doi.org/10.1155/2014/738298
Álvares CA, Svidzinski TI, Consolaro ME. Candidiasis vulvovaginal: Host predisposing factors and virulence of the yeasts. J Bras Patol Med Lab. 2007;43(5):319-27. https://doi.org/10.1590/S1676-24442007000500004 DOI: https://doi.org/10.1590/S1676-24442007000500004
Fan S, Liu X, Liang Y. Miconazole nitrate vaginal suppository 1,200 mg versus oral fluconazole 150 mg in treating severe vulvovaginal candidiasis. Gynecol Obstet Invest. 2015;80(2):113-8. https://doi.org/10.1159/000371759 PMid:25720546 DOI: https://doi.org/10.1159/000371759
Sobel JD. Factors involved in patient choice of oral or vaginal treatment for vulvovaginal candidiasis. Patient Prefer Adherence. 2013;8:31-4. https://doi.org/10.2147/PPA.S38984 PMid:24368881 DOI: https://doi.org/10.2147/PPA.S38984
Pappas PG, Lionakis MS, Arendrup MC, Ostrosky-Zeichner L, Kullberg BJ. Invasive candidiasis. Nat Rev Dis Primers. 2018;4:18026. https://doi.org/10.1038/nrdp.2018.26 PMid:29749387 DOI: https://doi.org/10.1038/nrdp.2018.26
Leusink P, van de Pasch S, Teunissen D, Laan ET, Lagro-Janssen AL. The relationship between vulvovaginal candidiasis and provoked vulvodynia: A systematic review. J Sex Med. 2018;15(9):1310-21. https://doi.org/10.1016/j.jsxm.2018.07.011 PMid:30145093 DOI: https://doi.org/10.1016/j.jsxm.2018.07.011
Leusink P, van Moorsel D, Bor H, Donker GA, Lucassen P, Teunissen D, et al. Is uncertain vulvovaginal candidiasis a marker of vulvodynia? A study in a Dutch general practice research database. BJGP Open. 2017;1(2):bjgpopen17X100905. https://doi.org/10.3399/bjgpopen17X100905 PMid:30564664 DOI: https://doi.org/10.3399/bjgpopen17X100905
Bauters TG, Dhont MA, Temmerman MI, Nelis HJ. Prevalence of vulvovaginal candidiasis and susceptibility to fluconazole in women. Am J Obstet Gynecol. 2002;187(3):569-74. https://doi.org/10.1067/mob.2002.125897 PMid:12237629 DOI: https://doi.org/10.1067/mob.2002.125897
Fidel PL Jr., Cutright JL, Sobel JD. Efficacy of D0870 treatment of experimental Candida vaginitis. Antimicrob Agents Chemother. 1997;41(7):1455-9. https://doi.org/10.1128/AAC.41.7.1455 PMid:9210665 DOI: https://doi.org/10.1128/AAC.41.7.1455
Perea S, López-Ribot JL, Kirkpatrick WR, McAtee RK, Santillán RA, Martínez M, et al. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother. 2001;45(10):2676-84. https://doi.org/10.1128/AAC.45.10.2676-2684.2001 PMid:11557454 DOI: https://doi.org/10.1128/AAC.45.10.2676-2684.2001
Pfaller MA, Diekema DJ. Rare and emerging opportunistic fungal pathogens: Concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol. 2004;42(10):4419-31. https://doi.org/10.1128/JCM.42.10.4419-4431.2004 PMid:15472288 DOI: https://doi.org/10.1128/JCM.42.10.4419-4431.2004
Berretta AA, de Castro PA, Cavalheiro AH, Fortes VS, Bom VP, Nascimento AP, et al. Evaluation of mucoadhesive gels with propolis (EPP-AF) in preclinical treatment of candidiasis vulvovaginal infection. Evid Based Complement Alternat Med. 2013;2013:641480. https://doi.org/10.1155/2013/641480 PMid:23997797 DOI: https://doi.org/10.1155/2013/641480
Júnior UP, Cabrera SP, da Silva TM, da Silva EM, Camara CA, Silva TM. Geopropolis gel for the adjuvant treatment of candidiasis-formulation and in vitro release assay. Rev Bras Farmacogn. 2019;29(3):278-86. https://doi.org/10.1016/j.bjp.2019.02.010 DOI: https://doi.org/10.1016/j.bjp.2019.02.010
Farida S, Sahlan M, Rohmatin E, Adawiyah R. The beneficial effect of Indonesian propolis wax from Tetragonula sp. as a therapy in limited vaginal candidiasis patients. Saudi J Biol Sci. 2020;27(1):142-6. https://doi.org/10.1016/j.sjbs.2019.06.010 PMid:31889828 DOI: https://doi.org/10.1016/j.sjbs.2019.06.010
Haghdoost NS, Salehi TZ, Khosravi A, Sharifzadeh A. Antifungal activity and influence of propolis against germ tube formation as a critical virulence attribute by clinical isolates of Candida albicans. J Mycol Med. 2016;26(4):298-305. https://doi.org/10.1016/j.mycmed.2015.11.004 PMid:27789229 DOI: https://doi.org/10.1016/j.mycmed.2015.11.004
de Lima NC, Ratti BA, Mendonça PD, Murata G, Pereira RR, Nakamura CV, et al. Propolis increases neutrophils response against Candida albicans through the increase of reactive oxygen species. Future Microbiol. 2018;13:221-30. https://doi.org/10.2217/fmb-2017-0112 PMid:29302986 DOI: https://doi.org/10.2217/fmb-2017-0112
Guo N, Liu J, Wu X, Bi X, Meng R, Wang X, et al. Antifungal activity of thymol against clinical isolates of fluconazolesensitive and-resistant Candida albicans. J Med Microbiol. 2009;58(8):1074-9. https://doi.org/10.1099/jmm.0.008052-0 PMid:19528168 DOI: https://doi.org/10.1099/jmm.0.008052-0
Andrade JT, de Figueiredo GF, Cruz LF, de Morais SE, Souza CD, Pinto FC, et al. Efficacy of curcumin in the treatment of experimental vulvovaginal candidiasis. Rev Iberoam Micol. 2019;36(4):192-9. https://doi.org/10.1016/j.riam.2019.01.003 PMid:31757595 DOI: https://doi.org/10.1016/j.riam.2019.01.003
Fallacara A, Baldini E, Manfredini S, Vertuani S. Hyaluronic acid in the third millennium. Polymers (Basel). 2018;10(7):701. https://doi.org/10.3390/polym10070701 PMid:30960626 DOI: https://doi.org/10.3390/polym10070701
Garantziotis S, Savani RC. Hyaluronan biology: A complex balancing act of structure, function, location and context. Matrix Biology. 2019;78-79:1-10. https://doi.org/10.1016/j.matbio.2019.02.002 PMid: 30802498 DOI: https://doi.org/10.1016/j.matbio.2019.02.002
Cermelli C, Cuoghi A, Scuri M, Bettua C, Neglia RG, Ardizzoni A, et al. In vitro evaluation of antiviral and virucidal activity of a high molecular weight hyaluronic acid. Virol J. 2011;8:141. https://doi.org/10.1186/1743-422X-8-141 PMid:21439070 DOI: https://doi.org/10.1186/1743-422X-8-141
Ardizzoni A, Neglia RG, Baschieri MC, Cermelli C, Caratozzolo M, Righi E, et al. Influence of hyaluronic acid on bacterial and fungal species, including clinically relevant opportunistic pathogens. J Mater Sci Mater Med. 2011;22(10):2329-38. https://doi.org/10.1007/s10856-011-4408-2 PMid:21892787 DOI: https://doi.org/10.1007/s10856-011-4408-2
Parolin C, Marangoni A, Laghi L, Foschi C, Palomino RA, Calonghi N, et al. Isolation of vaginal Lactobacilli and characterization of anti-candida activity. PLoS One. 2015;10(6):e0131220. https://doi.org/10.1371/journal.pone.0131220 PMid:26098675 DOI: https://doi.org/10.1371/journal.pone.0131220
Iannitti T, Lodi D, Palmieri B. Intra-articular injections for the treatment of osteoarthritis: Focus on the clinical use of hyaluronic acid. Drugs R D. 2011;11(1):13-27. https://doi.org/10.2165/11539760-000000000-00000 PMid:21142290 DOI: https://doi.org/10.2165/11539760-000000000-00000
Palmieri B, Rottigni V, Iannitti T. Preliminary study of highly cross-linked hyaluronic acid-based combination therapy for management of knee osteoarthritis-related pain. Drug Des Dev Ther. 2013;7:7-12. https://doi.org/10.2147/DDDT.S37330 PMid:23326188 DOI: https://doi.org/10.2147/DDDT.S37330
Coacci A, Palmieri B. Efficacy and tolerability of a nutraceutical in pearls formulation in the treatment of skin photo-aging. Pilot study. Progr Nutr. 2013;15(2):90-8.
Chen J, Geng L, Song X, Li H, Giordan N, Liao Q. Evaluation of the efficacy and safety of hyaluronic acid vaginal gel to ease vaginal dryness: A multicenter, randomized, controlled, open-label, parallel-group, clinical trial. J Sex Med. 2013;10(6):1575-84. https://doi.org/10.1111/jsm.12125 PMid:23574713 DOI: https://doi.org/10.1111/jsm.12125
Iannitti T, Rottigni V, Palmieri B. A pilot study to compare two different hyaluronic acid compounds for treatment of knee osteoarthritis. Int J Immunopathol Pharmacol. 2012;25(4):1093-8. https://doi.org/10.1177/039463201202500426 PMid:23298499 DOI: https://doi.org/10.1177/039463201202500426
Dos Santos CC, Uggioni ML, Colonetti T, Colonetti L, Grande AJ, da Rosa MI. Hyaluronic acid in postmenopause vaginal atrophy: A systematic review. J Sex Med. 2021;18(1):156-66. https://doi.org/10.1016/j.jsxm.2020.10.016 PMid:33293236 DOI: https://doi.org/10.1016/j.jsxm.2020.10.016
Kranke P, Bennett MH, James MM, Debus SE, Schnabel A, Weibel S. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev. 2015;2015(6):Cd004123. https://doi.org/10.1002/14651858.CD004123.pub4 PMid:26106870 DOI: https://doi.org/10.1002/14651858.CD004123.pub4
Bennett MH, Feldmeier J, Hampson NB, Smee R, Milross C. Hyperbaric oxygen therapy for late radiation tissue injury. Cochrane Database Syst Rev. 2016;4(4):Cd005005. https://doi.org/10.1002/14651858.CD005005.pub4 PMid:27123955 DOI: https://doi.org/10.1002/14651858.CD005005.pub4
Clarke RE, Tenorio LM, Hussey JR, Toklu AS, Cone DL, Hinojosa JG, et al. Hyperbaric oxygen treatment of chronic refractory radiation proctitis: A randomized and controlled double-blind crossover trial with long-term follow-up. Int J Radiat Oncol Biol Phys. 2008;72(1):134-43. https://doi.org/10.1016/j.ijrobp.2007.12.048 PMid:18342453 DOI: https://doi.org/10.1016/j.ijrobp.2007.12.048
Marx RE, Johnson RP, Kline SN. Prevention of osteoradionecrosis: A randomized prospective clinical trial of hyperbaric oxygen versus penicillin. J Am Dent Assoc. 1985;111(1):49-54. https://doi.org/10.14219/jada.archive.1985.0074 PMid:3897335 DOI: https://doi.org/10.14219/jada.archive.1985.0074
Mader JT, Adams KR, Couch LA, Sutton TE. Potentiation of tobramycin by hyperbaric oxygen in experimental Pseudomonas aeruginosa osteomyelitis. In: Abstracts of the 27th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology; 1987.
Rud AK, Bjørgo S, Kristensen GB, Kongsgaard UE. Hyperbaric oxygen therapy for late radiation tissue injury in gynaecological patients. Support Care Cancer. 2009;17(12):1517-21. https://doi.org/10.1007/s00520-009-0619-1 PMid:19319575 DOI: https://doi.org/10.1007/s00520-009-0619-1
Melamed Y. Hyperbaric oxygen therapy (HBO) for radiation necrosis-physician awareness is required. Harefuah. 2018;157(8):517-9. PMid:30175568
Peña-Villalobos I, Casanova-Maldonado I, Lois P, Prieto C, Pizarro C, Lattus J, et al. Hyperbaric oxygen increases stem cell proliferation, angiogenesis and wound-healing ability of WJ-MSCS in diabetic mice. Front Physiol. 2018;9:995. https://doi.org/10.3389/fphys.2018.00995 PMid:30104981 DOI: https://doi.org/10.3389/fphys.2018.00995
Hadanny A, Lang E, Copel L, Meir O, Bechor Y, Fishlev G, et al. Hyperbaric oxygen can induce angiogenesis and recover erectile function. Int J Impot Res. 2018;30(6):292-9. https://doi.org/10.1038/s41443-018-0023-9 PMid:29773856 DOI: https://doi.org/10.1038/s41443-018-0023-9
Memar MY, Yekani M, Alizadeh N, Baghi HB. Hyperbaric oxygen therapy: Antimicrobial mechanisms and clinical application for infections. Biomed Pharmacother. 2019;109:440-7. https://doi.org/10.1016/j.biopha.2018.10.142 PMid:30399579 DOI: https://doi.org/10.1016/j.biopha.2018.10.142
John BV, Chamilos G, Kontoyiannis DP. Hyperbaric oxygen as an adjunctive treatment for zygomycosis. Clin Microbiol Infect. 2005;11(7):515-7. https://doi.org/10.1111/j.1469-0691.2005.01170.x PMid:15966968 DOI: https://doi.org/10.1111/j.1469-0691.2005.01170.x
Segal E, Menhusen MJ, Shawn S. Hyperbaric oxygen in the treatment of invasive fungal infections: A single-center experience. Isr Med Assoc J. 2007;9(5):355-7. PMid:17591371
Gudewicz TM, Mader JT, Davis CP. Combined effects of hyperbaric oxygen and antifungal agents on the growth of Candida albicans. Aviat Space Environ Med. 1987;58(7):673-8. PMid:3304267
Condemi L, Di Giuseppe J, Carpini GD, Garoia F, Frega A, Ciavattini A. Vaginal natural oxygenation device (VNOD) for concomitant administration of hyaluronic acid and topical hyperbaric oxygen to treat vulvo-vaginal atrophy: A pilot study. Eur Rev Med Pharmacol Sci. 2018;22(23):8480-6. https://doi.org/10.26355/eurrev_201812_16548 PMid:30556890
Palmieri B, Iannitti T, Capone S, Fistetto G, Arisi E. Second opinion clinic: Is the Web Babel Syndrome treatable? Clin Ter. 2011;162(6):575-83. PMid:22262332
Palmieri B, Capone S, Fistetto G. Second opinion consultation: Is Babel-web syndrome curable? Recenti Prog Med. 2011;102(1):43. PMid:21516671
Palmieri B, Iannitti T. The web babel syndrome. Patient Educ Couns. 2011;85(2):331-3. https://doi.org/10.1016/j.pec.2011.02.019 DOI: https://doi.org/10.1016/j.pec.2011.02.019
Palmieri B, Laurino C, Vadalà M. The “second opinion medical network”. Int J Pathol Clin Res. 2017;3(1)1-7. https://doi.org/10.23937/2469-5807/1510056 DOI: https://doi.org/10.23937/2469-5807/1510056
Pavletic AJ, Hawes SE, Geske JA, Bringe K, Polack SH. Experience with routine vaginal pH testing in a family practice setting. Infect Dis Obstet Gynecol. 2004;12(2):63-8. https://doi.org/10.1080/10647440400009839 PMid:15739819 DOI: https://doi.org/10.1080/10647440400009839
Huppert JS, Hesse EA, Bernard MC, Bates JR, Gaydos CA, Kahn JA. Accuracy and trust of self-testing for bacterial vaginosis. J Adolesc Health. 2012;51(4):400-5. https://doi.org/10.1016/j.jadohealth.2012.01.017 PMid:22999842 DOI: https://doi.org/10.1016/j.jadohealth.2012.01.017
Skovoroda AR, Klishko AN, Gusakyan DA, Mayevskii YI, Yermilova V, Oranskaya G, et al. Quantitative analysis of the mechanical characteristics of pathologically changed soft biological tissues. Biophysics. 1995;40(6):1359-64.
Friedman RM, Hester KD, Green BG, LaMotte RH. Magnitude estimation of softness. Exp Brain Res. 2008;191(2):133-42. https://doi.org/10.1007/s00221-008-1507-5 PMid:18679665 DOI: https://doi.org/10.1007/s00221-008-1507-5
Ophir J, Céspedes I, Ponnekanti H, Yazdi Y, Li X. Elastography: A quantitative method for imaging the elasticity of biological tissues. Ultrason Imaging. 1991;13(2):111-34. https://doi.org/10.1177/016173469101300201 PMid:1858217 DOI: https://doi.org/10.1177/016173469101300201
Parker KJ, Huang SR, Musulin RA, Lerner RM. Tissue response to mechanical vibrations for “sonoelasticity imaging”. Ultrasound Med Biol. 1990;16(3):241-6. https://doi.org/10.1016/0301-5629(90)90003-U PMid:2194336 DOI: https://doi.org/10.1016/0301-5629(90)90003-U
Sarvazyan AP, Rudenko OV, Swanson SD, Fowlkes JB, Emelianov SY. Shear wave elasticity imaging: A new ultrasonic technology of medical diagnostics. Ultrasound Med Biol. 1998;24(9):1419-35. https://doi.org/10.1016/s0301-5629(98)00110-0 PMid:10385964 DOI: https://doi.org/10.1016/S0301-5629(98)00110-0
Eaton AA, Baser RE, Seidel B, Stabile C, Canty JP, Goldfrank DJ, et al. Validation of clinical tools for vaginal and vulvar symptom assessment in cancer patients and survivors. J Sex Med. 2017;14(1):144-51. https://doi.org/10.1016/j.jsxm.2016.11.317 PMid:28011209 DOI: https://doi.org/10.1016/j.jsxm.2016.11.317
Hunt TK, Pai MP. The effect of varying ambient oxygen tensions on wound metabolism and collagen synthesis. Surg Gynecol Obstet. 1972;135(4):561-7. PMid:5077722
Tandara AA, Mustoe TA. Oxygen in wound healing—more than a nutrient. World J Surg. 2004;28(3):294-300. https://doi.org/10.1007/s00268-003-7400-2 PMid:14961188 DOI: https://doi.org/10.1007/s00268-003-7400-2
Camporesi EM, Bosco G. Mechanisms of action of hyperbaric oxygen therapy. Undersea Hyperb Med. 2014;41(3):247-52. PMid:24984320
Tezel A, Fredrickson GH. The science of hyaluronic acid dermal fillers. J Cosmet Laser Ther. 2008;10(1):35-42. https://doi.org/10.1080/14764170701774901 PMid:18330796 DOI: https://doi.org/10.1080/14764170701774901
Grimaldi EF, Restaino S, Inglese S, Foltran L, Sorz A, Di Lorenzo G, et al. Role of high molecular weight hyaluronic acid in postmenopausal vaginal discomfort. Minerva Ginecol. 2012;64(4):321-9. PMid:22728576
Costantino D, Guaraldi C. Effectiveness and safety of vaginal suppositories for the treatment of the vaginal atrophy in postmenopausal women: An open, non-controlled clinical trial. Eur Rev Med Pharmacol Sci. 2008;12(6):411-6. PMid:19146203
Parolin C, Abruzzo A, Giordani B, Oliver JC, Marangoni A, Luppi B, et al. Anti-candida activity of hyaluronic acid combined with Lactobacillus crispatus lyophilised supernatant: A new antifungal strategy. Antibiotics (Basel). 2021;10(6):628. https://doi.org/10.3390/antibiotics10060628 PMid:34070335 DOI: https://doi.org/10.3390/antibiotics10060628
Quaranta L, Ottolina J, Parma M, Chionna R, Sileo F, Dindelli M, et al. An alternative approach for the treatment of vaginal atrophy. Minerva Ginecol. 2014;66(4):377-81. PMid:25020056
Leppilahti M, Hellström P, Tammela TL. Effect of diagnostic hydrodistension and four intravesical hyaluronic acid instillations on bladder ICAM-1 intensity and association of ICAM-1 intensity with clinical response in patients with interstitial cystitis. Urology. 2002;60(1):46-51. https://doi.org/10.1016/s0090-4295(02)01613-8 PMid:12100920 DOI: https://doi.org/10.1016/S0090-4295(02)01613-8
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2022 Beniamino Palmieri, Leone Condemi, Elena Bertozzi, Flavio Garoia, Maria Vadalà (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0
